REC added 2.49% to Rs 96.80 after the company recorded 1.5% rise in consolidated net profit to Rs 2732.12 crore on a 0.9% decline in total income to Rs 9,964 crore in Q2 FY23 over Q2 FY22.
Sales rise 18.24% to Rs 89.53 crore
Sales rise 3.63% to Rs 450.93 crore
The domestic equity benchmarks traded near the flat line, with some positive bias, in mid-afternoon trade. The Nifty traded below the 17,700 level. IT shares witnessed some bit of profit booking after advancing in the past two sessions. At 14:25 IST, the barometer index, the S&P BSE Sensex, was up 42.21 points or 0.07% to 59,586.17. The Nifty 50 index gained 28.70 points or 0.16% […]
The World Bank stated today that global agricultural prices are expected to decline 5% next year. Wheat prices in the third quarter of 2022 fell nearly 20 percent but remain 24 percent higher than a year ago. The decline in agricultural prices in 2023 reflects a better-than-projected global wheat crop, stable supplies in the rice market, and the resumption of grain exports from Ukraine. Metal […]
Gland Pharma Ltd saw volume of 30.49 lakh shares by 14:14 IST on NSE, a 15.76 fold spurt over two-week average daily volume of 1.94 lakh shares

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.